0
Synergistic Pathways
VEGF + Actin regulation
0+
Combined Studies
BPC-157 (200+) + TB-500 (170+)
0%
Faster Healing
TB-500 re-epithelialization
0
Research Areas
Tendon & Ligament · Wound Healing · Vascular Repair & more
How It Works
How BPC-157 / TB-500 works
The pathways BPC-157 / TB-500 acts on — and what each one does. The animation traces its signal outward from the compound to every target it engages.
Signalling pathways studied in preclinical models · illustrative
Angiogenesis & Cytoprotection
BPC-157
BPC-157 upregulates VEGF expression and promotes new blood vessel formation, delivering nutrients and oxygen to damaged tissue. It also activates the NO system and demonstrates broad cytoprotective properties.
VEGF-mediated angiogenesis Nitric oxide system modulation Gastric and tissue cytoprotection
Cell Migration & Actin Regulation
TB-500
TB-500 sequesters G-actin monomers and promotes cytoskeletal remodeling, enabling repair cells to migrate to injury sites. It also activates integrin-linked kinase (ILK) for tissue repair signaling.
Actin-mediated cell migration Integrin-linked kinase activation Anti-fibrotic remodeling
Complementary Repair Cascade
Synergy
BPC-157 initiates vascular support (blood flow to injury), while TB-500 mobilizes repair cells to the site. Together they address two distinct phases of tissue repair — perfusion and cellular migration.
Phase 1: Blood flow restoration (BPC-157) Phase 2: Cell mobilization (TB-500) Combined anti-inflammatory effects
Uses & Applications
What BPC-157 / TB-500 is researched for
The main areas BPC-157 / TB-500 is being studied for — and the study-reported figures behind them. Musculoskeletal
Tendon & Ligament
BPC-157 accelerates tendon healing while TB-500 enhances cell migration to the injury site for coordinated soft tissue repair.Chang et al. 2014 Dermatology
Wound Healing
TB-500 promotes dermal healing and reduces scarring; BPC-157 provides vascular support for nutrient delivery to wound sites.Malinda et al. 2007 Cardiovascular
Vascular Repair
BPC-157 promotes angiogenesis via the NO system while TB-500 supports cardiac cell migration through ILK activation.Sikiric et al. 2019 Anti-Inflammatory
Inflammation Control
Both peptides demonstrate anti-inflammatory properties through distinct mechanisms, creating a more controlled healing environment.Sikiric et al. 2011
Study-reported magnitudes
Representative figures from published research. Bars fill as you scroll.
BPC-157 Tendon Healing72%
TB-500 Cell Migration85%
BPC-157 GHR Expression700%
TB-500 Wound Closure61%
Figures are representative of published research findings and shown for reference.
Molecular Structure
The BPC-157 / TB-500 molecule
An interactive 3D model rendered from the compound record — rotate and explore its structure.
Molecular model
Sequence length blend
Physical form Lyophilized powder blend
Documented purity ≥99% by HPLC
Third-Party Verified
Independently tested. Verifiably pure.
Every batch of BPC-157 / TB-500 is sent to an accredited independent laboratory before it ships. Here is what we screen for.
HPLC Purity AnalysisConfirms the peptide is ≥99% pure
Mass SpectrometryVerifies the exact molecular identity
Heavy Metals ScreeningLead, arsenic, cadmium & mercury — Pass
Endotoxins (LAL)Bacterial endotoxin levels — Pass
Sterility TestingNo microbial contamination — Pass
Net Peptide ContentActual peptide mass per vial verified
Certificate of Analysis · Freedom DiagnosticPASS
HPLC Purity ≥99%
Identity Mass-spec confirmed
Endotoxin (LAL) Pass
Net content Verified
Compound Information
Full specification
Components BPC-157 + TB-500 (Thymosin Beta-4) BPC-157 Sequence 15 amino acids (Gly-Glu-Pro-Pro-Pro...) TB-500 Fragment 43-amino acid active region of Tβ4 Form Lyophilized powder blend Purity ≥99% per component (HPLC verified) Testing Third-party HPLC, Mass Spec, Endotoxin Storage (Lyophilized) -20°C for long-term stability Storage (Reconstituted) 2–8°C, use within 14-21 days Solubility Bacteriostatic water for reconstitution COA Included with every order Strength 20mg Purity (HPLC) >99% (HPLC) Appearance White to off-white powder Stability 24 months from manufacture date when stored properly
FAQ
Common questions about BPC-157 / TB-500
BPC-157 and TB-500 target complementary repair mechanisms. BPC-157 promotes blood vessel formation (angiogenesis) to deliver nutrients to injured tissue, while TB-500 mobilizes repair cells through actin regulation. Together they address both vascular support and cellular migration phases of tissue repair.
No. The combination has not been studied as a single formulation in clinical trials. The synergy rationale is based on complementary mechanisms from individual component research (200+ BPC-157 studies, 170+ TB-500 studies). Both are well-studied individually in preclinical models.
No. Neither BPC-157 nor TB-500 is FDA approved for any indication. This blend is sold exclusively for in vitro laboratory research purposes and is not intended for human consumption.
Store lyophilized at -20°C for long-term stability. After reconstitution with bacteriostatic water, refrigerate at 2-8°C and use within 14-21 days. Both components maintain stability under standard peptide storage conditions.
Each component undergoes independent third-party testing including HPLC for purity verification, mass spectrometry for molecular weight confirmation, and endotoxin testing. A Certificate of Analysis is included with every order.
Published Literature
Cited Sources
Peer-reviewed literature
Independent published research indexed from PubMed and peer-reviewed journals — not Eon Peptides claims.
For Research Use Only.
Not for human or veterinary use. For in-vitro laboratory research only. These statements have not been evaluated by the FDA; this product is not intended to diagnose, treat, cure, or prevent any disease. Sold exclusively to qualified researchers and institutions.